Steven Hamner - Medical Properties President
| MPW Stock | USD 4.77 0.15 3.25% |
President
Mr. R. Steven Hamner is a Chief Financial Officer, Executive Vice President, Director of Medical Properties Trust Inc. Mr. Hamner served as our Executive Vice President and Chief Accounting Officer. From October 2001 through March 2004, he was the Managing Director of Transaction Analysis LLC, a company that provided interim and projectoriented accounting and consulting services to commercial real estate owners and their advisors. From June 1998 to September 2001, he was Vice President and Chief Financial Officer of United Investors Realty Trust, a publicly traded REIT. For the ten years prior to becoming an officer of United Investors Realty Trust, he was employed by the accounting and consulting firm of Ernst Young LLP and its predecessors since 2005.
| Age | 63 |
| Tenure | 19 years |
| Address | 1000 Urban Center Drive, Birmingham, AL, United States, 35242-2225 |
| Phone | 205 969 3755 |
| Web | https://www.medicalpropertiestrust.com |
Medical Properties Management Efficiency
Return On Tangible Assets is likely to climb to -0.03 in 2024. Return On Capital Employed is likely to drop to 0 in 2024. At this time, Medical Properties' Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 17.2 B in 2024, despite the fact that Other Current Assets are likely to grow to (884.5 M). Medical Properties' management efficiency ratios could be used to measure how well Medical Properties manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Laurie Becker | Healthpeak Properties | 44 | |
| Mark Kennedy | Global Medical REIT | N/A | |
| David Dupuy | Community Healthcare Trust | 54 | |
| Leigh Stach | Community Healthcare Trust | 57 | |
| W Barnes | Community Healthcare Trust | 63 | |
| Jeffrey Theiler | Healthpeak Properties | 50 | |
| John Spaid | National Health Investors | 64 | |
| Daniel Klein | Healthpeak Properties | 56 | |
| Del Taylor | Healthpeak Properties | 67 | |
| Page Barnes | Community Healthcare Trust | 64 | |
| Talya NevoHacohen | Sabra Healthcare REIT | 64 | |
| D Mendelsohn | National Health Investors | 59 | |
| Bradley Page | Healthpeak Properties | 60 | |
| Mark Theine | Healthpeak Properties | 41 | |
| Jeff Theiler | Healthpeak Properties | 46 | |
| Roland Hart | Community Healthcare Trust | N/A | |
| Michael Willman | Community Healthcare Trust | N/A | |
| Allen Webb | Global Medical REIT | 50 | |
Management Performance
| Return On Equity | -0.0685 | ||||
| Return On Asset | 0.0031 |
Medical Properties Trust Leadership Team
Elected by the shareholders, the Medical Properties' board of directors comprises two types of representatives: Medical Properties inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Properties' management team and ensure that shareholders' interests are well served. Medical Properties' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Properties' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sherry Kellett, Independent Director | ||
| G Dawson, Independent Director | ||
| Reynolds Thompson, Director | ||
| William Mckenzie, Co-Founder, Director and Member of Investment Committee | ||
| Emily Murphy, Independent Director | ||
| Glenn Orr, Independent Director | ||
| Steven CPA, Executive Founder | ||
| Steven Dawson, Independent Director | ||
| Andrew CFA, Senior Communications | ||
| Daniel Sparks, Independent Director | ||
| Rosa Hooper, Assistant Operations | ||
| Tim Berryman, Director of Investor Relations | ||
| Elizabeth Pitman, Independent Director | ||
| C Thompson, Independent Director | ||
| Emmett McLean, Chief Operating Officer, Executive Vice President, Secretary | ||
| Caterina Mozingo, Independent Director | ||
| Kevin Hanna, Chief Accounting Officer, Vice President Controller | ||
| Edward Aldag, Co-Founder, Chairman, CEO and President and Chairman of Investment Committee | ||
| Michael Stewart, Lead Independent Director | ||
| Jamey Ramsey, Managing Tax | ||
| Robert Holmes, Lead Independent Director | ||
| Charles Lambert, Treasurer VP | ||
| Steven Hamner, Chief Financial Officer, Executive Vice President, Director | ||
| Larry Portal, Senior CEO | ||
| James Hanna, VP Officer | ||
| R Hamner, Chief Financial Officer, Executive Vice President, Director | ||
| Lucas Savage, VP Acquisitions |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medical Properties a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0685 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | 1.50 % | ||||
| Current Valuation | 12.72 B | ||||
| Shares Outstanding | 599.1 M | ||||
| Shares Owned By Insiders | 1.56 % | ||||
| Shares Owned By Institutions | 74.73 % | ||||
| Number Of Shares Shorted | 206.64 M | ||||
| Price To Earning | 13.88 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Medical Stock analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.49) | Dividend Share 0.88 | Earnings Share (0.93) | Revenue Per Share 1.48 | Quarterly Revenue Growth (0.13) |
The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.